Floatz logo

315 assets in Malignant Pancreatic Neoplasm

Therapeutic assets addressing Malignant Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Trastuzumab
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP1CCC (48)
Trifluridine
Malignant Pancreatic Neoplasm
Emory UniversityP1/2CCC (48)
yl-13027
Malignant Pancreatic Neoplasm
Shanghai YingLi Pharmaceutical Co. Ltd.P1/2CCC (48)
Aguix
Malignant Pancreatic Neoplasm
Dana-Farber Cancer InstituteP1/2CC (47)
Bms-986504
Malignant Pancreatic Neoplasm
Northwestern UniversityP1/2CC (47)
Cbp-1019
Malignant Pancreatic Neoplasm
Coherent Biopharma (Hefei) Co., Ltd.P1/2CC (47)
Claudin18.2 Car-T Cells
Malignant Pancreatic Neoplasm
Essen BiotechP1/2CC (47)
Fluoromisonidazole
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2CC (47)
Mesenchymal Stem Cells Derived Exosomes
Malignant Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (47)
Pegcetacoplan
Malignant Pancreatic Neoplasm
Roswell Park Cancer InstituteP1/2CC (47)
qs-21
Malignant Pancreatic Neoplasm
University of Kansas Medical CenterP2CC (47)
Rintatolimod
Malignant Pancreatic Neoplasm
Joachim Aerts, MD PhDP1/2CC (47)
SL-28
Malignant Pancreatic Neoplasm
Second Life TherapeuticsP1/2CC (47)
Sotorasib
Malignant Pancreatic Neoplasm
Devalingam MahalingamP1/2CC (47)
Trastuzumab Deruxtecan
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P1/2CC (47)
Cambritaxestat
Malignant Pancreatic Neoplasm
iOncturaP1/2CC (46)
Entrectinib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP1CC (46)
il15-transpresenting wt1-targeted dendritic cell vaccine
Malignant Pancreatic Neoplasm
University Hospital, AntwerpP1/2CC (46)
Pertuzumab
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP1CC (46)
Bet Bromodomain Inhibitor Zen-3694
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P1/2CC (45)
Conteltinib
Malignant Pancreatic Neoplasm
Shouyao Holdings (Beijing) Co. LTDP1/2CC (45)
Ebnk-001
Malignant Pancreatic Neoplasm
Essen BiotechP1/2CC (45)
ibi363
Malignant Pancreatic Neoplasm
Ruijin HospitalP1/2CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Malignant Pancreatic Neoplasm
Zhejiang UniversityP1/2CC (45)
Interleukin-15
Malignant Pancreatic Neoplasm
Essen BiotechP1/2CC (45)
Narmafotinib
Malignant Pancreatic Neoplasm
Amplia Therapeutics LimitedP1/2CC (45)
Pelareorep
Malignant Pancreatic Neoplasm
Oncolytics BiotechP1/2CC (45)
Penpulimab
Malignant Pancreatic Neoplasm
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1/2CC (45)
Perflubutane
Malignant Pancreatic Neoplasm
Flemming ForsbergP1/2CC (45)
Recombinant Human Il12/15-Pdl1B Oncolytic Hsv-1 )
Malignant Pancreatic Neoplasm
Zhejiang UniversityP1/2CC (45)
Rmc-6236
Malignant Pancreatic Neoplasm
Tango Therapeutics, Inc.P1/2CC (45)
Rmc-9805
Malignant Pancreatic Neoplasm
Tango Therapeutics, Inc.P1/2CC (45)
tng462
Malignant Pancreatic Neoplasm
Tango Therapeutics, Inc.P1/2CC (45)
Trifluridine/Tipiracil Hydrochloride Combination Agent Tas-102
Malignant Pancreatic Neoplasm
Oncolytics BiotechP1/2CC (45)
[99mTc]Tc-HYNIC-FAPI
Malignant Pancreatic Neoplasm
Tomsk National Research Medical Center of the Russian Academy of SciencesP1CC (43)
a2b530
Malignant Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (43)
a2b543
Malignant Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (43)
a2b694
Malignant Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (43)
Autologous Mesothelin-Specific Tcr-T Cells
Malignant Pancreatic Neoplasm
Fred Hutchinson Cancer CenterP1CC (43)
Azeliragon
Malignant Pancreatic Neoplasm
Cantex PharmaceuticalsP1/2CC (43)
Bendamustine
Malignant Pancreatic Neoplasm
Fred Hutchinson Cancer CenterP1CC (43)
Berzosertib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P1CC (43)
Bosentan
Malignant Pancreatic Neoplasm
City of Hope Medical CenterP1CC (43)
Canerpaturev
Malignant Pancreatic Neoplasm
Takara Bio Inc.P1CC (43)
Carbon Nanoparticle-Loaded Iron
Malignant Pancreatic Neoplasm
Sichuan Enray Pharmaceutical Sciences CompanyP1/2CC (43)
Cholestyramine
Malignant Pancreatic Neoplasm
City of Hope Medical CenterP1CC (43)
cht102
Malignant Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Copper Cu 64-Dota-A2Dm
Malignant Pancreatic Neoplasm
City of Hope Medical CenterP1CC (43)
Egfr Fpbmc
Malignant Pancreatic Neoplasm
University of VirginiaP1/2CC (43)
Emavusertib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P1CC (43)
Showing 151 to 200 of 315 assets
PreviousPage 4 of 7Next